Samchully Pharm. Co., Ltd.
Records under this name other than patents Samchully Pharm. Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Samchully Pharm. Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,901,289 | Preparation of nucleotide oligomer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,486,905 | Use of FLJ25416 gene Formerly held Lapsed on the fee record Ended Jul 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2025 | From the USPTO record |
| US 7,304,154 | Method for producing 2-deoxy-L-ribose Term ended Term ended Dec 17, 2024 · From the USPTO record | Term ended | Term ended Dec 17, 2024 | From the USPTO record |
| US 8,114,987 | Preparation method of 2-deoxy-L-ribose Lapsed on the fee record Ended Feb 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 14, 2024 | From the USPTO record |
| US 7,049,447 | Aziridine derivatives and their preparation methods Term ended Term ended Aug 2, 2022 · From the USPTO record | Term ended | Term ended Aug 2, 2022 | From the USPTO record |
| US 6,573,388 | Ethylaziridine derivatives and their preparation methods Term ended Term ended Feb 18, 2022 · From the USPTO record | Term ended | Term ended Feb 18, 2022 | From the USPTO record |
| US 6,596,521 | Method for manufacturing organic acid by high-efficiency continuous fermentation Lapsed on the fee record Ended Jul 22, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 22, 2015 | From the USPTO record |